The SPOT Project : Motivational Interviewing in Conjunction With Rapid HIV Testing
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01931345 |
|
Recruitment Status :
Completed
First Posted : August 29, 2013
Last Update Posted : October 25, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| High-risk Sex | Behavioral: Motivational Interviewing Counseling Behavioral: Standard counseling | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 900 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Prevention |
| Official Title: | The SPOT Project: Effect of Counseling Based on Motivational Interviewing Offered in Conjunction With Rapid HIV Testing on the Occurrence of Unprotected Anal Sex and Its Determinants Among Men Who Have Sex With Men (MSM) in Montreal |
| Study Start Date : | July 2013 |
| Actual Primary Completion Date : | March 2016 |
| Actual Study Completion Date : | April 2016 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Motivational Interviewing Counseling
Counseling developed by the research team based on a motivational interviewing approach
|
Behavioral: Motivational Interviewing Counseling
Counseling developed by the research team based on a motivational interviewing approach |
|
Active Comparator: Standard counseling
Counseling based on Quebec guidelines for rapid HIV testing
|
Behavioral: Standard counseling
Counseling based on Quebec guidelines for rapid HIV testing |
- Change from baseline occurrence of at-risk anal intercourse at 6 months [ Time Frame: Prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3) ]Occurrence of at-risk anal intercourse will be assessed prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3).
- Change from baseline importance that participants accord to taking the necessary steps to protect themselves from HIV at 6 months [ Time Frame: Prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3) ]Importance that participants accord to taking the necessary steps to protect themselves from HIV will be assessed prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3).
- Change from baseline perceived personal efficacy in protecting themselves from HIV at 6 months [ Time Frame: Prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3) ]Perceived personal efficacy in protecting themselves from HIV will be assessed prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3)
- Change from baseline intention to protect themselves from HIV at 6 months [ Time Frame: Prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3) ]Intention to protect themselves from HIV will be assessed prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3)
- Change from baseline extent to which participants have planned to protect themselves from HIV at 6 months [ Time Frame: Prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3) ]Extent to which participants have planned to protect themselves from HIV will be assessed prior to pre-test counseling at the start of participants' initial visit (baseline, T0), after post-test counseling at the end of the initial visit (T1), at 3 months after the initial visit (T2), and at 6 months after the initial visit (T3)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Male
- 18 years of age or older
- Resident of Quebec
- Able to understand French or English
- Unprotected anal sex with a man on at least one occasion in the last 3 years
- HIV-negative or HIV status unknown
Exclusion Criteria:
- Symptoms of fever (over 38°C), headache, muscular pain, fatigue, and/or swollen lymp
- Previously tested at SPOT
- Enrolled as a participant in the IPERGAY study
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01931345
| Canada, Quebec | |
| SPOT, 1223-A rue Amherst | |
| Montreal, Quebec, Canada, H2L 3K9 | |
| Principal Investigator: | Joanne Otis, Ph.D. | Université du Québec a Montréal |
| Responsible Party: | Jessica Caruso, Research Agent, Université du Québec a Montréal |
| ClinicalTrials.gov Identifier: | NCT01931345 |
| Other Study ID Numbers: |
SPOT |
| First Posted: | August 29, 2013 Key Record Dates |
| Last Update Posted: | October 25, 2016 |
| Last Verified: | October 2016 |
|
Rapid HIV testing MSM Motivational Interviewing HIV prevention |
HIV/AIDS At-risk anal intercourse Randomized trial |

